Location History:
- Merfy, FR (1998 - 2002)
- Reims Cedex, FR (2001 - 2011)
- Reims, Cedex, FR (2013)
Company Filing History:
7 out of 854 
4 out of 16 
1 out of 109 
Years Active: 1998-2013
Title: The Innovative Mind of Jean-Jacques Marcel Lohmann
Introduction
Jean-Jacques Marcel Lohmann, an esteemed inventor based in Reims Cedex, France, has made significant contributions to the field of pharmaceuticals with his inventive prowess. With a remarkable portfolio of 12 patents, his work primarily focuses on the development of innovative compounds with therapeutic applications for various diseases.
Latest Patents
Lohmann's latest patents include groundbreaking inventions related to chromenone derivatives and quinazoline derivatives. His patent on chromenone compounds involves the creation of specific chromenone structures and their pharmaceutically acceptable salts, designed for the treatment of cell proliferative disorders. This invention opens new avenues for medications targeting diseases associated with abnormal cell growth.
Similarly, his work on quinazoline derivatives details a novel range of compounds that have the potential to inhibit vascular endothelial growth factor (VEGF). This property is particularly valuable in the treatment of cancer and rheumatoid arthritis, highlighting Lohmann’s commitment to addressing critical health challenges through innovative chemistry.
Career Highlights
Throughout his career, Jean-Jacques Lohmann has earned a reputation for his expertise in pharmaceutical innovations. He has had the privilege of working with prominent firms such as Zeneca Limited and Zeneca Pharma S.A., where his contributions were instrumental in developing novel therapeutic agents. His extensive knowledge in the field of medicinal chemistry has led to valuable advancements in drug development.
Collaborations
Collaboration has played a significant role in Lohmann's career. He has collaborated with esteemed professionals like Andrew Peter Thomas and Laurent Francois Andre Hennequin, collectively contributing to the enhancement of pharmaceutical compounds and their applications. These collaborations have been pivotal in driving forward research initiatives and technological advancements in the industry.
Conclusion
Jean-Jacques Marcel Lohmann exemplifies the spirit of innovation through his extensive contributions to the field of pharmaceuticals. His recent patents underscore his commitment to developing compounds that not only advance medical science but also provide hope for patients suffering from serious health conditions. As he continues to explore new frontiers in drug discovery, Lohmann remains a prominent figure in the world of inventions and pharmaceutical innovation.